ArticleJournal of clinical medicine2025

Reported Adverse Events in Patients with CF Receiving Treatment with Elexacaftor/Tezacaftor/Ivacaftor: 5 Years Observational Study.

Francesca Lucca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.